Anti-Allergic & Anti-Inflammatory

Eyecrol (Eye Drops)
(Sodium Cromoglicate)

Each ml contains sodium cromoglicate 20 mg or 40 mg.

- Allergic conjunctivitis (acute, chronic, spring);
- Allergic keratitis and keratoconjunctivitis;
- Syndrome of “dry eyes”;
- Overstrain and fatigue of eyes caused by allergic reactions (environmental factors, occupational hazard, household chemical goods, cosmetic goods, ophthalmic preparations, plants and domestic animals).

- Hypersensitivity to any drug ingredients;
- Pregnancy;
- Lactation (breast feeding);
- Infancy under 4 years.

Transient burning and blurred vision, conjunctive hyperemia and edema, lacrimation, sensation of a foreign body in an eye, eye dryness.

The drug is instilled into a conjunctive sac. The application frequency depends on severity of inflammation.
Children older 4 years: 1-2 drops of 2% solution in both eyes 4-6 times a day in equal time intervals (gradually increase dosage intervals if clinical effect occurs).
Adults and adolescents: 1-2 drops of 4% solution in both eyes 4-6 (up to 8) times a day in equal time intervals (gradually increase dosage intervals if clinical effect occurs).

It reduces the necessity of application of ophthalmic agents containing glucocorticosteroids.

It is not recommended to wear soft lenses during therapy. Patients wearing contact lenses should apply only putting them away. Lenses may be put again in 15-20 minutes following instillation.


Application during pregnancy and lactation is contraindicated.
In case of application during lactation breast-feeding should be ceased.

10 ml in a plastic vial with a dropper and screw cup in a carton box with an insert.

Anti-Allergic &

Clodifen (Eye Drops)

Eyecrol (Eye Drops)

Medexol (Eye/Ear Drops)

Medrolgin (Eye Drops)

Neladex (Eye Ointment)

Neladex (Eye/Ear Drops)

Pallada (Eye Drops)

Tafazol (Eye Drops)

 Events & Exhibitions


The most likely diagnosis is:

a. traction retinal detachment
b. tigroid fundus
c. epiretinal membrane
d. thyroid-related ophthalmopathy

WOC 2014 in Tokyo, Japan
Online submission of abstracts will open on March 1, 2013. The deadline for abstract submission is July 26, 2013 at midnight in Tokyo. Submissions will be reviewed by the WOC 2014 Scientific Program Committee. Primary authors will be notified of acceptance by early October, 2013.

Researchers Develop Gene Therapy That Could Correct A Common Form Of Blindness
A new gene therapy method developed by University of Florida researchers has the potential to treat a common form of blindness that strikes both youngsters and adults.

Oxygen Therapy Helps Heal Chemical and Thermal Burns in the Eyes
Scientists at the Department of Ophthalmology, Ahvaz Jundishapur University of Medical Sciences, treated 24 eyes of 22 patients with acute chemical and thermal burns in their eyes.

Glaucoma Causes Higher Risk of Falls Among Older Adults
Glaucoma can affect a person's downward field of view, and this seems to be causing a higher risk of falls resulting in injury among older people with the eye disease.

Why Do Birds Fly into Power Lines? Is Poor Vision the Problem?
esearch suggests that collision with human structures is the largest unintended human cause of bird deaths

Diabetes and Hypertension Increase Glaucoma Risk
People with diabetes and/or hypertension are more likely to develop open-angle glaucoma (OAG) as well.

Be Careful Out There: Fireworks Caused 1,300 Eye Injuries in One Month in 2010
Sparklers caused about 200 U.S. eye injuries during a one-month period in 2010.

High Visual Perception Ability in Autistic People Explained
It has been noticed before that autistic people are highly able to process visual information, and this may be why.

Why Cold Temperatures Increase Eye Dryness
In fact, the meibum can solidify in cold temperatures and block the meibomian gland ducts

Home      |      Site Map      |      Terms of Use      |      Privacy Policy

© 2012 World Medicine Ophthalmics. All Rights Reserved.